Notice of interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 19.10.2021KRKA, d.d., Novo mesto (KRK-2)8567CLamegom 25 mg filmom obalené tablety (tbl flm 98x25 mg (blis.OPA/Al/PVC/Al))20.10.2021R
 19.10.2021Pfizer Europe MA EEIG (PFI-BE-3)72568UNASYN P.O.S. 250 mg/5 ml (plu por 1x60 ml (fľ.HDPE))5.11.2021R
 19.10.2021Pfizer Europe MA EEIG (PFI-BE-3)62362DALACIN V 2 % (crm vag 1x40 g (tuba PE))26.10.2021R
 18.10.2021Takeda Manufacturing Austria AG (TKM)97250KIOVIG 100 mg/ml infúzny intravenózny roztok (sol inf 1x200 ml/20 g (liek.inj.skl.))18.10.2021R
 18.10.2021Zentiva k.s. (ZNT-3)4699DXanirva 20 mg filmom obalené tablety (tbl flm 98x20 mg (blis.PVC/Al))19.10.2021O
 18.10.2021Zentiva k.s. (ZNT-3)4688DXanirva 15 mg filmom obalené tablety (tbl flm 28x15 mg (blis.PVC/Al))19.10.2021O
 18.10.2021Zentiva k.s. (ZNT-3)4696DXanirva 20 mg filmom obalené tablety (tbl flm 28x20 mg (blis.PVC/Al))19.10.2021O
 18.10.2021Zentiva k.s. (ZNT-3)4692DXanirva 15 mg filmom obalené tablety (tbl flm 98x15 mg (blis.PVC/Al))19.10.2021O
 18.10.2021Zentiva k.s. (ZNT-3)4690DXanirva 15 mg filmom obalené tablety (tbl flm 42x15 mg (blis.PVC/Al))19.10.2021O
 18.10.2021Zentiva, k.s. (ZNT-1)5802BMixor 80 mg/5 mg (tbl 28x80 mg/5 mg (blis.OPA/Al/PVC/Al))19.10.2021O
 18.10.2021Astellas Pharma s.r.o. (ASL-CZ-1)42283Eligard 22,5 mg (plv iol 1x22,5 mg+1x solv. (striek.inj.napl."A"s PP viečkom+striek.inj.napl."B"+ihla))18.10.2021R
 15.10.2021LEO Pharma A/S (LEO-2)30770Daivobet gél (gel der 1x60 g (fľ.HDPE))1.11.2021Z
 15.10.2021LEO Pharma A/S (LEO-2)0701BDaivobet gél (gel der 1x60 g (fľ.HDPE+aplikátor PP))1.11.2021Z
 15.10.2021GlaxoSmithKline (Ireland) Limited (GAG-IE-2)46800INTEGRILIN 2 mg/ml injekčný roztok (sol inj 1x10 ml/20 mg (liek.inj.skl.))15.10.2021R
 14.10.2021Takeda Manufacturing Austria AG (TKM)97248KIOVIG 100 mg/ml infúzny intravenózny roztok (sol inf 1x100 ml/10 g (liek.inj.skl.))14.10.2021O

Subject means: R-Break, O-Renew or Z-Cancellation of human drug delivery


Date from
From
To